Mogrify and Astellas Announce Collaboration to Conduct Research on In Vivo Regenerative Medicine Approaches to Address Sensorineural Hearing Loss

Mogrify Limited and Astellas Pharma, Inc. announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.